Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist
Version of Record online: 29 JAN 2009
2000 Nature Publishing Group
British Journal of Pharmacology
Volume 130, Issue 3, pages 539–548, June 2000
How to Cite
Hagan, J. J., Price, G. W., Jeffrey, P., Deeks, N. J., Stean, T., Piper, D., Smith, M. I., Upton, N., Medhurst, A. D., Middlemiss, D. N., Riley, G. J., Lovell, P. J., Bromidge, S. M. and Thomas, D. R. (2000), Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist. British Journal of Pharmacology, 130: 539–548. doi: 10.1038/sj.bjp.0703357
- Issue online: 29 JAN 2009
- Version of Record online: 29 JAN 2009
- (Received January 1, 2000, Revised March 14, 2000, Accepted March 14, 2000)
- Human 5-HT7 receptor;
- adenylyl cyclase;
The novel 5-HT7 receptor antagonist, SB-269970-A, potently displaced [3H]-5-CT from human 5-HT7(a) (pKi 8.9±0.1) and 5-HT7 receptors in guinea-pig cortex (pKi 8.3±0.2).
5-CT stimulated adenylyl cyclase activity in 5-HT7(a)/HEK293 membranes (pEC50 7.5±0.1) and SB-269970-A (0.03–1 μM) inhibited the 5-CT concentration-response with no significant alteration in the maximal response. The pA2 (8.5±0.2) for SB-269970-A agreed well with the pKi determined from [3H]-5-CT binding studies.
5-CT-stimulated adenylyl cyclase activity in guinea-pig hippocampal membranes (pEC50 of 8.4±0.2) was inhibited by SB-269970-A (0.3 μM) with a pKB (8.3±0.1) in good agreement with its antagonist potency at the human cloned 5-HT7(a) receptor and its binding affinity at guinea-pig cortical membranes.
5-HT7 receptor mRNA was highly expressed in human hypothalamus, amygdala, thalamus, hippocampus and testis.
SB-269970-A was CNS penetrant (steady-state brain : blood ratio of ca. 0.83 : 1 in rats) but was rapidly cleared from the blood (CLb=ca. 140 ml min−1 kg−1). Following a single dose (3 mg kg−1) SB-269970 was detectable in rat brain at 30 (87 nM) and 60 min (58 nM). In guinea-pigs, brain levels averaged 31 and 51 nM respectively at 30 and 60 min after dosing, although the compound was undetectable in one of the three animals tested.
5-CT (0.3 mg kg−1 i.p.) induced hypothermia in guinea-pigs was blocked by SB-269970-A (ED50 2.96 mg kg−1 i.p.) and the non-selective 5-HT7 receptor antagonist metergoline (0.3–3 mg kg−1 s.c.), suggesting a role for 5-HT7 receptor stimulation in 5-CT induced hypothermia in guinea-pigs.
SB-269970-A (30 mg kg−1) administered at the start of the sleep period, significantly reduced time spent in Paradoxical Sleep (PS) during the first 3 h of EEG recording in conscious rats.
British Journal of Pharmacology (2000) 130, 539–548; doi:10.1038/sj.bjp.0703357